Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.4745 EUR -5.1%
Market Cap: 19.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Net Margin
Celyad Oncology SA

-10 766.7%
Current
-12 663%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10 766.7%
=
Net Income
-7.8m
/
Revenue
72k

Net Margin Across Competitors

Country Company Market Cap Net
Margin
BE
Celyad Oncology SA
XBRU:CYAD
19.7m EUR
-10 767%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
300.2B USD
9%
US
Amgen Inc
NASDAQ:AMGN
159.1B USD
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD
-5%
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD
0%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
AU
CSL Ltd
ASX:CSL
137.3B AUD
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD
34%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.1B EUR
-14%
Country BE
Market Cap 19.7m EUR
Net Margin
-10 767%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 300.2B USD
Net Margin
9%
Country US
Market Cap 159.1B USD
Net Margin
13%
Country US
Market Cap 126.6B USD
Net Margin
-5%
Country US
Market Cap 114.6B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 137.3B AUD
Net Margin
18%
Country US
Market Cap 87.6B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Celyad Oncology SA.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10 766.7%
=
Net Income
-7.8m
/
Revenue
72k
What is the Net Margin of Celyad Oncology SA?

Based on Celyad Oncology SA's most recent financial statements, the company has Net Margin of -10 766.7%.